857231P
C18:1 Cyclic LPA
Manufacturer: Sigma Aldrich
CAS Number: 799268-69-2
Synonym(S): 1-O-octadecenyl-sn-glycero-2,3-cyclic-phosphate (ammonium salt); AGP 18:1
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 MG | 857231P-1-MG | In Stock | ₹ 46,006.25 |
857231P - 1 MG
In Stock
Quantity
1
Base Price: ₹ 46,006.25
GST (18%): ₹ 8,281.125
Total Price: ₹ 54,287.375
Assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 1 mg (857231P-1mg)
manufacturer/tradename
Avanti Polar Lipids 857231P
lipid type
cardiolipinsphospholipids
shipped in
dry ice
storage temp.
−20°C
SMILES string
CCCCCCCC/C=C\CCCCCCCCOC[C@@H]1COP(O1)([O-])=O.[NH4+]
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | 799268-69-2 | 1-O-(9Z-octadecenyl)-sn-glycero-2,3-cyclic-phosphate (ammonium salt) | A2B Chem | ₹ 54,758.40 |
Related Products
Description
- General description: Cyclic phosphatidic acid (cPA) is a naturally occurring analog of the growth factor-like phospholipid mediator, lysophosphatidic acid (LPA). The sn-2 hydroxy group of CPA forms a 5-membered ring with the sn-3 phosphate. cPA affects numerous cellular functions, including anti-mitogenic regulation of the cell cycle,[1]induction of stress fiber formation,[2] inhibition of tumor cell invasion and metastasis,[3] and regulation of differentiation and survival of neuronal cells.[4] Interestingly, many of these cellular responses caused by cPA oppose those of LPA despite the activation of apparently overlapping receptor populations.
- Packaging: 5 mL Amber Glass Screw Cap Vial (857231P-1mg)
SAFETY INFORMATION
WGK
WGK 3
Compare Similar Items
Show Difference
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (857231P-1mg)
manufacturer/tradename: Avanti Polar Lipids 857231P
lipid type: cardiolipinsphospholipids
shipped in: dry ice
storage temp.: −20°C
SMILES string: CCCCCCCC/C=C\CCCCCCCCOC[C@@H]1COP(O1)([O-])=O.[NH4+]
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 1 × 1 mg (857231P-1mg)
manufacturer/tradename:
Avanti Polar Lipids 857231P
lipid type:
cardiolipinsphospholipids
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
CCCCCCCC/C=C\CCCCCCCCOC[C@@H]1COP(O1)([O-])=O.[NH4+]
Assay: ≥99% (TLC)
form: powder
packaging: pkg of 1 × 25 mg (857235P-25MG)pkg of 1 × 5 mg (857235P-5MG)
manufacturer/tradename: Avanti Polar Lipids
lipid type: phospholipids
shipped in: dry ice
storage temp.: −20°C
SMILES string: [NH4+].CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP(O)([O-])=S)OC
Assay:
≥99% (TLC)
form:
powder
packaging:
pkg of 1 × 25 mg (857235P-25MG)pkg of 1 × 5 mg (857235P-5MG)
manufacturer/tradename:
Avanti Polar Lipids
lipid type:
phospholipids
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
[NH4+].CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP(O)([O-])=S)OC
Assay: 99%
form: powder
packaging: __
manufacturer/tradename: __
lipid type: __
shipped in: __
storage temp.: 2-8°C
SMILES string: NC(Cc1ccc(Br)cc1)C(O)=O
Assay:
99%
form:
powder
packaging:
__
manufacturer/tradename:
__
lipid type:
__
shipped in:
__
storage temp.:
2-8°C
SMILES string:
NC(Cc1ccc(Br)cc1)C(O)=O
Assay: 85%
form: solid
packaging: __
manufacturer/tradename: __
lipid type: __
shipped in: __
storage temp.: __
SMILES string: [H][C@@]12CCN(C[C@H]1C=C)[C@]([H])(C2)[C@@H](O)c3ccnc4ccccc34
Assay:
85%
form:
solid
packaging:
__
manufacturer/tradename:
__
lipid type:
__
shipped in:
__
storage temp.:
__
SMILES string:
[H][C@@]12CCN(C[C@H]1C=C)[C@]([H])(C2)[C@@H](O)c3ccnc4ccccc34